Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake

Pharmacology, Biochemistry, and Behavior
M Foster OliveClyde W Hodge

Abstract

Corticotropin-releasing factor (CRF) is widely distributed throughout the brain and has been shown to mediate numerous endocrine and behavioral responses to stressors. During acute ethanol withdrawal, CRF release is increased in the central nucleus of the amygdala (CeA), and there is evidence to suggest that this activation of amygdala CRF systems may mediate the anxiogenic properties of the ethanol withdrawal syndrome. The present study was conducted to determine if another CRF-containing limbic structure, the bed nucleus of the stria terminalis (BNST), we would exhibit similar increases in CRF neurotransmission during ethanol withdrawal. Rats were administered an ethanol-containing (6.7% v/v) or control liquid diet for 2 weeks and subsequently implanted with microdialysis probes into the lateral BNST. A 50-75% increase in dialysate CRF levels was observed following removal of the ethanol-containing diet, while no changes were observed in control animals. When ethanol-withdrawn animals were given subsequent access to the ethanol-containing diet, dialysate CRF levels returned to basal levels. However, when ethanol-withdrawn animals were given subsequent access to the control diet, dialysate CRF levels increased further to 101% ...Continue Reading

References

Jun 1, 1978·The Journal of Pharmacy and Pharmacology·B TabakoffR F Ritzmann
Feb 1, 1992·Alcoholism, Clinical and Experimental Research·D M Gallant, J M Pèna
Jan 1, 1991·Psychopharmacology·H A BaldwinK T Britton
Jan 1, 1986·Annual Review of Physiology·C L Rivier, P M Plotsky
Sep 1, 1985·Drug and Alcohol Dependence·F WeiseR D Koch
Jan 1, 1982·Alcoholism, Clinical and Experimental Research·C S Lieber, L M DeCarli
Sep 28, 1995·Nature·L CahillJ L McGaugh
Mar 1, 1994·Pharmacology, Biochemistry, and Behavior·B J Cole, G F Koob
Dec 29, 1995·Annals of the New York Academy of Sciences·A E Calogero
Sep 2, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·S BruggerJ A Martinez
Apr 8, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S N KatnerF Weiss
Jul 23, 1999·Annals of the New York Academy of Sciences·J S de Olmos, L Heimer
Sep 1, 2000·Brain Research. Brain Research Reviews·Y ShahamJ Stewart
Sep 26, 2000·Addiction·G F Koob
Dec 7, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M J NijsenV M Wiegant
Jan 5, 2001·Alcoholism, Clinical and Experimental Research·D D RasmussenC W Wilkinson
May 5, 2001·Peptides·G N SmaginA J Dunn

❮ Previous
Next ❯

Citations

Aug 3, 2010·Psychopharmacology·Nicholas W Gilpin, George F Koob
Jun 6, 2008·Brain Structure & Function·David L Walker, Michael Davis
Jan 30, 2008·Journal of Molecular Neuroscience : MN·Milagros MéndezJosé Manuel Pérez-Luna
Nov 5, 2005·Brain Research. Brain Research Reviews·Adrie W Bruijnzeel, Mark S Gold
Nov 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George F Koob
Jun 12, 2013·Neuropharmacology·George F KoobOlivier George
Jun 5, 2003·Brain Research. Molecular Brain Research·Yan ZhouMary Jeanne Kreek
Jan 16, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Catherine A MarcinkiewczAdrie W Bruijnzeel
Aug 21, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael DavisChristian Grillon
Feb 5, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Emily G LoweryTodd E Thiele
Feb 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joseph G Oberlander, Leslie P Henderson
Jun 2, 2009·Nature Reviews. Drug Discovery·George F KoobBarbara J Mason
Sep 1, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Adrie W BruijnzeelMark S Gold
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Manoj P DandekarNishikant K Subhedar
Jun 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michal BajoMarisa Roberto
Jul 26, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·George F Koob, Michel Le Moal
Dec 25, 2007·Annual Review of Psychology·George F Koob, Michel Le Moal
Jan 18, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yuval SilbermanDanny G Winder
May 1, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Walter FrancesconiPietro Paolo Sanna
Jun 22, 2010·Future Neurology·Scott Edwards, George F Koob
Jan 25, 2014·Frontiers in Neuroendocrinology·Eric P ZorrillaGeorge F Koob
Feb 11, 2014·Experimental Neurology·Samara A M BobzeanLinda I Perrotti
Feb 26, 2016·Physiology & Behavior·Anne Q Fosnocht, Lisa A Briand
Mar 13, 2012·Neuroscience and Biobehavioral Reviews·Adrie W Bruijnzeel
Nov 24, 2011·Physiology & Behavior·Olivier GeorgeGeorge F Koob
Mar 3, 2010·Behavioural Brain Research·Adrie W BruijnzeelHidetaka Yamada
Nov 17, 2009·Alcohol·Katie WitkiewitzMarisa Roberto
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence
Aug 18, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Walter FrancesconiPietro Paolo Sanna
Jul 15, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·D L WalkerM Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.